key: cord-0819611-tvln1bco
authors: Sundaram, M.; Calzavara, A.; Mishra, S.; Kustra, R.; Chan, A.; Hamilton, M. A.; Djebli, M.; Rosella, L. A.; Watson, T.; Chen, H.; Chen, B.; Baral, S.; Kwong, J.
title: The Individual and Social Determinants of COVID-19 in Ontario, Canada: A Population-Wide Study
date: 2020-11-12
journal: nan
DOI: 10.1101/2020.11.09.20223792
sha: 2b203ac33f5cbf3fbe1fab063263e506cbf8937d
doc_id: 819611
cord_uid: tvln1bco

Importance: Optimizing the public health response to reduce coronavirus disease 2019 (COVID-19) burden necessitates characterizing population-level heterogeneity of COVID-19 risks. However, heterogeneity in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing may introduce biased estimates depending on analytic design. Objective: Characterizing individual, environmental, and social determinants of SARS-CoV-2 testing and COVID-19 diagnosis. Design: We conducted cross-sectional analyses among 14.7 million people comparing individual, environmental, and social determinants among individuals who were tested versus not yet tested. Among those diagnosed, we used three analytic designs to compare predictors of: 1) individuals testing positive versus negative; 2) symptomatic individuals testing positive versus negative; and 3) individuals testing positive versus individuals not testing positive (i.e. testing negative or not being tested). Analyses included tests conducted between March 1 and June 20, 2020. Setting: Ontario, Canada. Participants: All individuals with [≥]1 healthcare system contact since March 2012, excluding individuals deceased before, or born after, March 1, 2020, or residing in a long-term care facility. Exposures: Individual-level characteristics (age, sex, underlying health conditions, prior healthcare use), area-based environmental (air pollution) exposures, and area-based social determinants of health (income, education, housing, marital status, race/ethnicity, and recent immigration). Main Outcomes and Measures: Odds of SARS-CoV-2 test, and of COVID-19 diagnosis. Results: Of a total of 14,695,579 individuals, 758,691 had been tested, of whom 25,030 (3.3%) tested positive. The further the odds of testing from the null, the more variability observed in the odds of diagnosis across analytic design, particularly among individual factors. There was less variability in testing by social determinants across analytic design. Residing in areas with highest household density (adjusted odds ratio: 2.08; 95%CI: 1.95-1.21), lowest educational attainment (adjusted odds ratio: 1.52; 95%CI: 1.44-1.60), and highest proportion of recent immigrants (adjusted odds ratio: 1.12; 95%CI: 1.07-1.16) were consistently related to increased odds of COVID-19 across analytic designs. Conclusions and Relevance: Where testing is limited, risk factors may be better estimated using population comparators rather than test-negative comparators. Optimizing COVID-19 responses necessitates investment and sufficient coverage of structural interventions tailored to heterogeneity in social determinants of risk, including household crowding and systemic racism.

6 119 Thus, to identify heterogeneity across potential determinants of COVID-19, we 120 examined individual, environmental, and social determinants associated with SARS-121

CoV-2 testing and diagnoses among 14.7 million individuals in Ontario, Canada. We 122 compared three analytic approaches to examine the role of selection biases. 22 123 124 Methods 125

We conducted an observational study using population-based laboratory and health 127 administrative databases from Ontario, Canada. Ontario has a single-payer health 128 system that provides universal access to hospital and physician services 25 and 129 laboratory testing. 26 We used data from individuals tested between March 1 and June 130 20, 2020 to identify determinants associated with testing, and then used three analytic 131 designs to identify determinants associated with laboratory-confirmed diagnosis of 132 134

We linked individual-level SARS-CoV-2 testing data from the Ontario Laboratories 136

Information System (OLIS) to relevant health-related datasets containing demographic, 137 healthcare use, and area-level information (eTable 1). These datasets were linked 138 using unique encoded identifiers and analyzed at ICES, a not-for-profit research 139 institute in Ontario. 27 To assess community transmission risks, we included individuals who were tested for 153 SARS-CoV-2 by polymerase chain reaction tests and were not residing in a long-term 154 care facility as of March 1, 2020 (Figure 1 ). For individuals with more than one test in 155 OLIS, we used the first positive or indeterminate test, or the first negative test if all tests 156 during the study period were negative. Never-tested individuals during the study period health conditions identified in the literature as associated with COVID-19 severity 2,29-32 165 or associated with symptoms similar to those caused by COVID-19, because severity 166 and symptoms may lead to differential testing and thus, selection bias; [33] [34] [35] [36] [37] [38] Social determinants were conceptualized as area-based variables that may signal 181 contact rates within and/or outside households [household density, uncoupled 

To identify determinants of testing, the outcome was defined as receipt of at least one 197 SARS-CoV-2 test during the study period. The comparator group comprised Ontario 198 residents who did not have a record of testing during the study period. Determinants of 199 testing were examined in unadjusted, age/sex-adjusted, and fully-adjusted logistic 200 regression models that included all determinants. The fully-adjusted model also 201 included a fixed-effect covariate for public health region. These are geographic areas in 202 which public health measures were differentially applied 50 and along which there may 203 be considerable variability in measured and unmeasured social determinants. 51 We 204 opted to include public health regions a priori in the model due to these predicted 205 variations in public health response. 206

To identify determinants of COVID-19, the outcome variable was a laboratory-confirmed 208 diagnosis. To explore the potential for effects of a variety of sources of bias from testing, 209

we compared the results according to different comparison sub-groups, by 210 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 characteristics that may have influenced the probability of being tested. We first 211 compared individuals who tested positive to individuals who tested negative ("pseudo-212 test-negative design"). Second, we restricted the analysis to individuals with 213 symptomatic illness, mirroring the test-negative design commonly used to assess 214 influenza vaccine effectiveness (the "true test-negative design"). 52 Third, we compared 215 all individuals who tested positive to all individuals who did not test positive (i.e., to 216 individuals who tested negative or were not tested; the "case-control design"). Potential 217 mechanisms of selection biases in each analytic design are outlined in eFigure 1A-C. 218

We then conducted unadjusted, age/sex-adjusted, and fully-adjusted logistic regression 220 models (including all determinants and public health region, as with testing) using each 221 of the three analytic approaches to identify heterogeneity in individual, environmental, 222 and social determinants of COVID-19 diagnosis. We interpreted each set of 223 determinants (individual, environmental, social) as independent analyses based on the 224 directed acyclic graphs (eFigure 1A-C). Statistical analyses were conducted using SAS 225 v. 9.4 (Cary, NC). 226 227

The use of data in this project was authorized under section 45 of Ontario's Personal 229

Health Information Protection Act, which does not require review by a Research Ethics 230

Board. 231 232

All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ;

Of 758,691 individuals tested during the study period, 25,030 (3.3%) received a 234 laboratory-confirmed diagnosis (Figure 1) . Only 11.8% of those tested had a symptom 235 recorded by the provider, 13.6% were considered asymptomatic, and 74.6% were 236 missing symptom information. 

In fully-adjusted analyses, odds of testing increased with age ( Table 2) . Males had 241 lower odds of testing than females. Nearly every underlying health condition was 242 associated with increased odds of testing, as were most measures of prior healthcare 243 use. In contrast, higher measures of ambient air pollution were associated with reduced 244 odds of testing. There was little variability in the odds of testing by most area-based 245 social determinants. However, areas with higher visible minority populations had lower 246 odds of testing, whereas areas with higher household income and greater percentages 247 of uncoupled individuals had higher odds of testing. Effect measures across nearly all 248 determinants appeared to be progressively attenuated from unadjusted, to age/sex-249 adjusted, to fully-adjusted regression models (eTable 2). 250 251

Choice of analytic design and comparison group restrictions had substantial influences 253 on the magnitude and direction of the association between individual-level determinants 254 and diagnosis ( Table 2) . Determinants associated with odds of testing further from the 255 null appeared to be more variable in terms of odds of diagnosis across analytic designs. 256 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; https://doi.org/10. 1101 For example, the odds of testing for adults aged ≥ 85 years compared to those aged <5 257 years deviated considerably from the null (adjusted odds ratio [aOR]=5.57; 95%CI, 258 5. 45-5.70) , and the odds of diagnosis differed between the pseudo-test-negative design 259 (aOR=1.72; 95%CI, 1.48-2.01), the true test-negative design (aOR=5.95; 95%CI, 3.57-260 9.92), and the case-control design (aOR=7.09; 95%CI, 6.08-8.26). Some health 261 conditions associated with higher odds of testing, such as chronic respiratory conditions, 262

and indicators of prior healthcare use appeared protective against COVID-19 using the 263 pseudo-test-negative design, but reverted to the null or showed increased odds of 264 diagnosis using the case-control design. As with testing, effect measures for COVID-19 265 diagnosis across all determinants appeared to be progressively attenuated from 266 unadjusted, to age/sex-adjusted, to fully-adjusted regression models (eTables 3-5). 267

Individual determinants of COVID-19 diagnosis using the case-control design 269

Using the case-control design, age, certain comorbidities (e.g., hypertension, diabetes, 270 dementia), and increased prior healthcare use were associated with increased odds of 271 COVID-19. In contrast, other comorbidities (e.g., cancer, substance abuse) and receipt 272 of influenza vaccine in the 2019-2020 season were associated with reduced odds of 273 diagnosis ( Table 2) . 274

Environmental determinants of COVID-19 diagnosis using the case-control design 276

The two highest categories of PM 2.5 exposure were associated with increased odds of 277 diagnosis, whereas no categories of exposure to NO 2 were associated with increased 278 odds of diagnosis consistently across analytic approaches. 279 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ;

Area-level social determinants independently associated with COVID-19 included higher 282 household income, increased receipt of social assistance, lower educational attainment, 283 greater percentages of uncoupled individuals, higher household density, increased 284 apartment building density, and greater percentages of recent immigrants. respectively. For testing, the associations were attenuated after adjustment for nearly all 289 determinants. The association for household income reversed direction following 290 adjustment. For diagnosis, the associations were attenuated after adjustment for all 291 social determinants except for household density. Similar to testing, the association with 292 COVID-19 for household income reversed direction following adjustment. 293 294

In this large-scale, population-based study, we identified social determinants as key 296 potential determinants for a diagnosis of COVID-19. We identified variability in 297 associations, likely due to selection biases, by analytic design across individual 298 determinants of COVID-19 diagnosis. 299

We identified increased odds of diagnosis associated with household density, 301 educational attainment, uncoupled status, and recent immigration, consistent with 302 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; findings from other settings. 51, 53, 54 In particular, the results concerning social 303 determinants and COVID-19 risk presented here suggest these social determinants are 304 not likely artifacts of selection bias from study design, given the consistency of findings 305 across different analytic approaches. Lower educational attainment or uncoupled status 306 may be associated with higher exposure risk through lower-paying jobs in the service 307 industry 55 and/or other high-exposure occupations, either because those jobs cannot be 308 done feasibly with proper protections, or because protective policies fail to be issued, 309 leaving workers at high risk. 56,57 Higher percentages of recent immigrants in an area 310

were associated with COVID-19 diagnosis, even after adjustment, although the 311 percentage of visible minorities was not. Both variables might represent residual 312 measures of mediators of systemic racism, potentiating relative risks of SARS-CoV-2 313 exposure and COVID-19 severity, 58-60 including COVID-19-related 314 hospitalization/death. 14,21,30,54 We found that an association between visible minority and 315 COVID-19 diagnosis in Ontario was attenuated after adjustment for individual, 316 environmental, and other social determinants. These findings likely reflect what is 317 already known about race and ethnicity as social constructs and social determinants of 318 health. 61 This is further supported by the attenuation of effect estimates from the 319 unadjusted, to age/sex-adjusted, to fully-adjusted models. Finally, the fact that there 320 was little variation in the odds of testing rates across levels of most of the social 321 determinants suggests that testing resources may not be prioritizing those who are most 322 at risk. 62 However, even with this finding, our results indicate that social determinants of 323 health play important roles in determining COVID-19 risk. Taken together, our findings 324 suggest a need to increase and/or redirect resources that specifically address social 325 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; determinants such as household density 48,63 (e.g., voluntary temporary isolation 326 hotels 64 ), proxies for occupational risk 56,60 (e.g., paid sick leave 65 ), and other mediators 327 of systemic racism 62,66,67 (e.g. community-led outreach testing 68 ). 328

We also identified the size and direction of influence that selection biases may have, 330

adding to the ongoing conversation on the challenges of interpreting determinants for 331 COVID-19 due to collider bias. 22 Although we did not directly explore each potential 332 collider mechanism, the pattern that emerged was that underlying health conditions 333 associated with COVID-19 severity 2 may have been prone to collider bias, as evidenced 334 by higher testing and a seemingly protective effect when using the test-negative designs 335 that reversed when using the case-control design. It is, however, also possible that a 336 high number of covariates in fully-adjusted models caused instability in effect measure 337 estimates for these covariates. Age also demonstrated a similar potential susceptibility 338 to collider bias, possibly mediated by COVID-19 severity and symptoms (i.e., older age 339 groups are more likely to develop severe/symptomatic infection if infected 2 ). Over the 340 study period, the testing criteria in Ontario shifted from returning symptomatic travellers 341 to severely symptomatic individuals and those with occupational exposure to additional 342 testing of asymptomatic individuals. [33] [34] [35] [36] 38 In our study, the restriction of the test-343 negative design to symptomatic individuals did not yield substantially different results 344 than the test-negative design including symptomatic and asymptomatic individuals, but 345 that may have been partly due to the extensive (74.6%) missingness of symptom 346 reporting in the testing data. We opted not to use multiple imputation methods to 347 determine symptom information because, at the time the analysis was conducted, 348 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ;

reported symptoms of COVID-19 were highly variable and the extent to which 349 individuals may have asymptomatic or pre-symptomatic illness was unclear, limiting our 350 confidence in the generalizability of existing information to individuals whose information 351 was missing. Thus, while there is an intuitive desire to compare test positivity rates 352 among those tested-a common metric of comparison across surveillance reports and 353 dashboards 69,70 -the risks of erroneously identifying a "risk/protective factor", 354

particularly individual determinants such as underlying health conditions, sex, and age, 355 are high and deserve careful interpretation by examining, as best possible, the reasons 356 for testing. 22 In the context of low overall levels of testing, the case-control design may 357 have mitigated some potential sources of selection bias, with the assumption that those 358 not tested are similar to those who tested negative. 21,22 Additionally, we found that some 359 underlying health conditions and prior healthcare use remained associated with 360 diagnoses, reflecting either unmeasured confounders or possible biological 361 susceptibility to infection if exposed; 15,16,71-73 and suggesting that strategies tailored to 362 reduce exposures among individuals characterized by these individual determinants 363 could also be important in risk-tailored prevention. 364 365 Finally, these analyses identified PM 2.5 as being related to the odds of COVID-19. It is 366 likely that some of this effect is due to underlying social determinants of health and 367 access to tests. Air pollution is often more intense, and results in worse health 368 outcomes, in areas with higher social deprivation. 74,75 However, existing studies have 369 also implicated environmental pollution as having a biological relationship to the risk and 370 severity of COVID-19 and other respiratory infections. 15, 16, 19 Taken together with other 371 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Results are also conditioned on the assumption that determinants remained constant 381 across the study period, whereas surveillance data suggest shifts in how infections 382

propagate between social networks. 76 Future analyses include examining changes in 383 the direction and magnitude of determinants over the course of the outbreak. Although 384 we generated directed acyclic graphs for the general categories of determinants to help 385 conceptualize and mitigate selection bias while also identifying plausible determinants, it 386 is possible that we over-adjusted when interpreting individual variables within each 387 category. 77 Our models also adjusted for public health region, within which many social 388 determinants cluster 51 , and thus we cannot infer from the results presented how social 389 determinants of COVID-19 risk may vary between and within these geographic regions. 390

Social determinants were measured at the area level and were not available at the 391 individual level; however, by describing individuals' neighbourhoods, analyses reflect 392 the role of structural and environmental determinants for individuals living amongst them. 393

Some important determinants identified in the prior literature, such as obesity, 8, 78 were 394 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. not available for our study. 79 Others, such as occupation, were not included due to 395 uncertainty related to quantifying and appropriately grouping the occupational 396 classifications available in the Census data at the area level. Medicine. This study was supported by ICES, which is funded by an annual grant from 414 the Ontario Ministry of Health and Long-Term Care (MOHLTC). The study sponsors did 415 not participate in the design and conduct of the study; collection, management, analysis 416 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; and interpretation of the data; preparation, review or approval of the manuscript; or the 417 decision to submit the manuscript for publication. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; 440 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. the Canadian Longitudinal Study on Aging. Gerontologist. 2020. 574 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. https://www.publichealthontario.ca/en/data-and-analysis/infectious-disease/covid-619 All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; Table 1 . Characteristics of study population tested and not tested for SARS-CoV-2 in Ontario (March 1, 2020 to June 20, 2020). Individuals were excluded if they had a listed age >105 years, had a listed postal code outside of Ontario, or had no record of contact with the healthcare system in the past 8 years (since March 2012). All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 12, 2020. ; 1 Figure 2. Unadjusted, sex/age adjusted, and fully adjusted association between social determinants and SARS-CoV-2 testing (panel A) and COVID-19 diagnosis (panel B), using the case-control design, in Ontario (March 1 to June 20, 2020). Fully-adjusted OR Forest plots show the odds of being tested for SARS-CoV-2, compared to the reference group (1 st quintile or 1 st category). In all cases, the first quintile/ category represents the lowest quintile of values for the variable at the dissemination area (DA)-level. For example, the lowest quintile of household income represents individuals living in the lowest 20% of DAs by income quintile. Age/ sexadjusted models are shown in Table 2 . Fully-adjusted models control for all variables listed in Table 2 , including (but not limited to) all variables shown in this figure; effect estimates and 95% CIs for all models shown here can be found in eTable 2.

A All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

19-data-surveillance/covid-19-data-tool

COVID-19 and cardiovascular 622 disease: from basic mechanisms to clinical perspectives

COVID-19 and diabetes: 625 Knowledge in progress

The COVID-19 pandemic: a new 627 challenge for syndromic surveillance

Air pollution, health and social 629 deprivation: A fine-scale risk assessment

Air Pollution, Social 631 Deprivation, and Mortality

Heterogeneity in risk, testing and outcome of 633 COVID-19 across outbreak settings in the Greater Toronto Area, Canada: an 634 observational study. medRxiv. 2020. 635 77. Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting 636 confounder and modifier coefficients

Obesity: A critical risk factor in the COVID-19 639 pandemic

NAAQS Table

2%) 466 (1.9%) 9,752 (11.4%) 152 (3.8%) 829,504 (6.0%)

8%) 113,026 (14.9%) Congestive heart failure

5%) 166,611 (22.0%) 457 (19.7%) 3,903 (15.6%) 15,245 (17.9%) 709 (17.5%) 2,926,432 (21.0%) 148,360 (19.6%) 215 (21.0%) 4,477 (17.9%) 17,690 (20.7%) 869 (21.4%) 2,978,444 (21.4%)

Chronic kidney disease c 1.31 (1.29, 1.32) 0.86 (0.80, 0.93) 1.04 (0.88, 1.23) 1.16 (1.08, 1.24) Immunocompromised d 1.30 (1.28